Over the past 12 months, 7 insiders at Dyne Therapeutics, Inc. filed 111 open-market SEC Form 4 transactions on DYN: 6 purchases worth $241K and 105 sales worth $96.3M. Insiders have been net sellers over this period. The most recent filing was on Jul 7, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 26 | Jason P Rhodes | SELL | 124.4K | $23.62 | $2.9M |
| Jul 6, 26 | Jason P Rhodes | SELL | 253.0K | $22.79 | $5.8M |
| Jun 29, 26 | Jason P Rhodes | SELL | 103.0K | $21.14 | $2.2M |
| Jun 26, 26 | Jason P Rhodes | SELL | 163.0K | $21.28 | $3.5M |
| Jun 25, 26 | Erick LuceraChief Financial Officer | SELL | 2.4K | $20.37 | $48K |
| Jun 25, 26 | Jason P Rhodes | SELL | 12.7K | $21.10 | $268K |
| Jun 24, 26 | Jason P Rhodes | SELL | 50.5K | $21.02 | $1.1M |
| Jun 23, 26 | Jason P Rhodes | SELL | 77.9K | $21.13 | $1.6M |
| Jun 23, 26 | Dirk Kersten | SELL | 71.6K | $21.47 | $1.5M |
| Jun 22, 26 | Dirk Kersten | SELL | 190.7K | $20.57 | $3.9M |
| Jun 18, 26 | Dirk Kersten | SELL | 46.9K | $20.07 | $941K |
| Jun 17, 26 | Dirk Kersten | SELL | 37.5K | $20.14 | $754K |
| Jun 16, 26 | John CoxCEO & President | SELL | 2.7K | $18.33 | $49K |
| Jun 16, 26 | Johanna Friedl-nadererChief Commercial Officer | SELL | 145 | $18.33 | $3K |
| Jun 16, 26 | Douglas KerrChief Medical Officer | SELL | 887 | $18.33 | $16K |
| Jun 8, 26 | Brian S Posner | BUY | 2.0K | $16.94 | $34K |
| Jun 3, 26 | Brian S Posner | BUY | 2.5K | $17.48 | $44K |
| May 26, 26 | Brian S Posner | BUY | 2.0K | $18.21 | $36K |
| May 20, 26 | Brian S Posner | BUY | 2.5K | $17.12 | $43K |
| May 13, 26 | John CoxCEO & President | SELL | 3.3K | $18.36 | $61K |
| May 13, 26 | Johanna Friedl-nadererChief Commercial Officer | SELL | 228 | $18.36 | $4K |
| May 13, 26 | Douglas KerrChief Medical Officer | SELL | 1.6K | $18.36 | $29K |
| May 13, 26 | Erick LuceraChief Financial Officer | SELL | 1.4K | $18.36 | $27K |
| May 6, 26 | Jason P Rhodes | SELL | 43.6K | $18.18 | $793K |
| May 5, 26 | Jason P Rhodes | SELL | 6.1K | $18.03 | $110K |
| May 4, 26 | Jason P Rhodes | SELL | 6.2K | $18.00 | $112K |
| Apr 28, 26 | Jason P Rhodes | SELL | 119.1K | $19.00 | $2.2M |
| Apr 27, 26 | Jason P Rhodes | SELL | 90.9K | $18.15 | $1.7M |
| Apr 24, 26 | Jason P Rhodes | SELL | 72.3K | $18.48 | $1.3M |
| Apr 23, 26 | Jason P Rhodes | SELL | 38.3K | $19.19 | $735K |
| Apr 22, 26 | Dirk Kersten | SELL | 2.7K | $20.00 | $53K |
| Apr 22, 26 | Jason P Rhodes | SELL | 150.9K | $19.68 | $3.0M |
| Apr 21, 26 | Dirk Kersten | SELL | 8.3K | $20.01 | $166K |
| Apr 21, 26 | Jason P Rhodes | SELL | 142.3K | $20.05 | $2.8M |
| Apr 20, 26 | Jason P Rhodes | SELL | 142.6K | $20.06 | $2.9M |
| Apr 20, 26 | Dirk Kersten | SELL | 125.3K | $20.07 | $2.5M |
| Apr 17, 26 | Dirk Kersten | SELL | 212.0K | $20.29 | $4.3M |
| Apr 16, 26 | Dirk Kersten | SELL | 11.1K | $21.10 | $235K |
| Apr 15, 26 | Dirk Kersten | SELL | 81.8K | $20.27 | $1.7M |
| Mar 11, 26 | Dirk KerstenDirector | SELL | 129.7K | $19.52 | $2.5M |
| Mar 11, 26 | Brian S PosnerDirector | BUY | 2.0K | $19.35 | $39K |
| Mar 10, 26 | Dirk KerstenDirector | SELL | 281.9K | $19.80 | $5.6M |
| Mar 9, 26 | Dirk KerstenDirector | SELL | 177.7K | $17.72 | $3.1M |
| Mar 6, 26 | Brian S PosnerDirector | BUY | 3.0K | $15.06 | $45K |
| Mar 5, 26 | John CoxCEO & President | SELL | 2.7K | $14.90 | $41K |
| Mar 5, 26 | Johanna Friedl-nadererChief Commercial Officer | SELL | 148 | $14.90 | $2K |
| Mar 5, 26 | Douglas KerrChief Medical Officer | SELL | 904 | $14.90 | $13K |
| Dec 5, 25 | John CoxCEO & President | SELL | 2.7K | $20.72 | $55K |
| Dec 5, 25 | Johanna Friedl-nadererChief Commercial Officer | SELL | 144 | $20.72 | $3K |
| Dec 5, 25 | Douglas KerrChief Medical Officer | SELL | 880 | $20.72 | $18K |
Over the past 12 months, insiders at Dyne Therapeutics, Inc. filed 6 open-market purchases worth $241K and 105 sales worth $96.3M on DYN, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 7, 26.
The largest recent open-market DYN insider purchase in our data was $45K by Brian S Posner, Director, filed on Mar 6, 26.
7 different insiders at Dyne Therapeutics, Inc. filed open-market SEC Form 4 transactions on DYN over the last 12 months.
InsiderTape plots every DYN insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Dyne Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →